Initiated the rapid development of a SARS-CoV-2 assay to combat COVID-19.
Received FDA EUA approval for SARS-CoV-2 test and launched CE-IVD approved High Volume SARS-CoV-2 test for global distribution.
Molecular Made Easy
Using real-time PCR, BioGX makes molecular testing easy with its novel Sample-Ready™ approach to test development, which incorporates all reagents – mixed and lyophilized – into one tube, plate or cartridge without the need for refrigeration. This Sample-Ready™ technology is at the core of the company’s worldwide offerings across clinical, food safety, pharma and water quality testing.
The company’s tests and reagents are fine-tuned to ensure the highest performance in any lab setting, from a sophisticated lab in a developed country, to a remote lab with limited infrastructure and resources, to outer space, where our products are used in the International Space Station.
Its portfolio of products includes a robust menu of CE-IVDs and EUA test panel options, from COVID-19 to respiratory, sexual health, enteric pathogens, drug resistance, meningitis, transplant and tropical disease. Its platform-agnostic, custom-designed solutions are available for LDTs in the U.S. and enable a lab to specify its choice of test and receive a high-performance mix of all the necessary reagents, primers and probes, lyophilized and in one tube.
Leadership Team
We have assembled a highly talented management team with decades of individual experience successfully developing and commercializing innovative clinical and molecular diagnostic products.

Shazi Iqbal, Ph.D.
Dr. Iqbal has over 20 years of experience building healthcare technologies and businesses in business development, corporate sales, global marketing and product development. Read more

Michael Vickery, Ph.D.
Dr. Vickery founded BioGX in 2007 and served as President and CEO until 2011. Read more

Shahin Iqbal, Ph.D.
Dr. Iqbal has over 20 years of experience in clinical and molecular diagnostics and is responsible for overall operations. Read more

Joey Curtis
Mr. Curtis is responsible for providing the global infrastructure, process and technology for BioGX’s global operations. Read more

Christopher Hughes
Prior to joining BioGX, Mr. Hughes led efforts for a diverse range of companies with the development and implementation of certified quality management systems. Read more

George Blackstone
Mr. Blackstone has served at BioGX in various senior R&D and quality management roles prior to his current position. Read more

Robert Martinez, Ph.D.
Dr. Martinez has over 20 years of experience in molecular biology, and manages global marketing and technical support efforts. Read more

Mohammed Merchant
Mr. Merchant brings over 20 years of experience in digital technology, e-commerce, and software product management in various industries. Read more
Milestones
2019-2020
2017-2018
Launched BioGX BV in Amsterdam.
Launched Global Partnership Initiative.2017-2018
2015-2016
Partnered with NASA for real-time PCR based analysis in Space.
NASA successfully conducted the first real-time gene expression analysis in space using BioGX Sample-Ready™ reagents on Cepheid SmartCycler.
Obtained ISO-13485 certification.2013-2014
Launched 20+ BioGX Sample-Ready™ molecular diagnostics assays for BD MAX™.
FDA issued guidance for Pharma Heparin Contamination using BioGX Sample-Ready™ molecular diagnostics reagents.
Launched 44+ LUO tests for BD MAX™.2013-2014
2010
Expanded our molecular diagnostics portfolio with 22 new Food Safety panels.
Awarded only FDA BAM EHEC PCR test and General Services Administration contract.